Answers are grounded in this paper and cite their sources.
Enzymatic debridement, particularly with Nexobrid®, has become a common method for selective removal of necrotic tissue in burn care.Nexobrid® acts through gelatinase activity and is typically applied within 72 h of injury following a 2-h eschar presoak.However, its efficacy in low-temperature burns is not well documented.We describe a case of third-degree low-temperature burns on a patient's back and right upper arm, where Nexobrid® was applied 12 days post-injury after a 2-hour pre-soaking.Necrotic tissue removal was incomplete, and additional surgical debridement was required.The relevant literature suggests that the poor efficacy may be due to limited collagen denaturation into gelatin in low-temperature burns or insufficient moisture penetration with a 2-h pre-soak.Low-temperature burns are often treated after delays, which may further reduce the effectiveness of the Nexobrid®.For such burns, early intervention or extended pre-soaking may improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Noro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: